89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

Steppe gold announces updated life-of-mine plan for ato gold mine to 2036, revealing higher revenues and profits

Steppe Gold Ltd (TSX:STGO, OTCQX:STPGF) has announced an updated life of mine (LOM) for its 100% owned ATO gold project in Mongolia, comprising a fur...

February 21, 2023, 7:41 am

Gilead (gild) reports positive data from urothelial cancer study

Gilead's (GILD) new and updated positive results from a phase II study show Trodelvy's rapid and durabl...

February 20, 2023, 1:32 pm

Saying goodbye to vaneck vectors africa index etf

The VanEck Vectors Africa Index ETF has not done well since I first bought in almost nine years ago. In my current clean-up phase, I finally let it go...

February 20, 2023, 9:00 am

Biovie: quick rise and fall of an alzheimer's disease drug developer

BioVie came out with phase 2 data in December. BIVI stock went up a lot, then fell equally badly, after...

February 20, 2023, 6:43 am

Iag share price braces for turbulence ahead of q3 earnings

IAG (LON: IAG) share price will be in the spotlight this week as the FTSE 100 constituent is scheduled to publish its quarterly and annual results. Th...

February 20, 2023, 4:17 am

Gbp/usd to break topside of 1.1850-1.2450 range post a consolidation phase – credit suisse

GBP/USD is expected to remain trapped in the approximate 1.1850-1.2450 range still, according to economists at Credit Suisse. Break below 1.1841 Janua...

February 17, 2023, 9:14 am

Moderna shares fall on mixed flu vaccine study results

Moderna Therapeutics Inc (NASDAQ:MRNA) shares have fallen more than 5% in pre-market trading after the biotechnology company reported mixed results fr...

February 17, 2023, 8:52 am

Boj has decided to launch pilot program on cbdc this april, says uchida

• Aim of pilot program is to test technical feasibility, utilise insights of private businesses
• ...

  February 17, 2023, 4:56 am

Bioxcel bxcl701: another step forward in the race for an mcrpc treatment

BioXcel has just published top-line data from the phase IIa trial of BXCL701 for mSCNC with very promis...

February 17, 2023, 1:09 am

Why shares of ocular therapeutix jumped this week

A promising report of a therapy in a phase 1 trial gave the stock a lift....

February 16, 2023, 5:15 pm

Canada silver cobalt works hits up to 29.9m of massive and semi-massive sulphides near surface at graal property in quebec

Canada Silver Cobalt Works Inc (TSX-V:CCW, OTCQB:CCWOF) (CCW) announced that it has received data from its ph...

February 16, 2023, 10:08 am

Algernon pharma says unit completes dosing of first cohort in its phase 1 clinical study of an intravenous formulation of dmt

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neuro), has completed dosing of the first cohort i...

February 16, 2023, 7:59 am

Bridgebio: if acoramidis completes comeback, this highly prized biotech's share price should soar

BridgeBio has some very significant price catalysts arriving in 2023 promising substantial upside should they be positive. Most important is ...

February 15, 2023, 12:38 am

Fresh off its merger, ouster-velodyne make a bet on smart infrastructure

With lidar companies Ouster and Velodyne officially merged, CEO Angus Pacala has identified the next phase ...

February 14, 2023, 4:01 pm

Intelligent bio solutions inc. reports fiscal 2023 second quarter financial results and operational highlights

– Second quarter total revenue and government support income increased over 100% year-over-year – – Government support income increased 52% for ...

February 14, 2023, 1:14 pm

Enphase energy, inc. (enph) is attracting investor attention: here is what you should know

Recently, Zacks.com users have been paying close attention to Enphase Energy (ENPH). This makes it wort...

February 14, 2023, 10:32 am

Vr resources confirms significant ree mineralogy and metallurgy details at hecla-kilmer project in ontario with scanning electron microprobe

VR Resources Ltd (TSX-V:VRR, OTCQB:VRRCF) has released a report on the first phase of the mineralogy an...

February 14, 2023, 9:33 am